We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Strategic Partnership for the Development of an Interferon-alpha Human Autoantibody

News   Feb 14, 2018 | Original story from ImmunoQure AG

 
Strategic Partnership for the Development of an Interferon-alpha Human Autoantibody
 
 
Advertisement
 

RELATED ARTICLES

New Cancer Vaccine Ready for Human Trials

News

A new cancer vaccine, comprised of human antibodies fused with tumor-specific protein, is ready to begin human testing.

READ MORE

Teknova Welcomes Stephen Gunstream as CEO

News

Teknova has announced the appointment of Stephen Gunstream as chief executive officer.

READ MORE

A Mirror-image Peptide Tumor Treatment

News

Scientists have developed a new approach to immunological tumor treatment. Their method is based on the specific blockade of an immune checkpoint by a stable "mirror-image" peptide.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE